TGFB1 and non-small cell lung carcinoma: We propose the existence of a TGF-β1-LINE-1-EMT axis that functions in normal and transformed bronchial epithelial cells as a critical effector pathway that can be targeted for development of optimized therapies for patients with NSCLC.